LUCD

Lucid Diagnostics Inc. Common Stock

0.78

USD

-0.02

-2.64%

Sep 11, 15:59 UTC -4

Closed

After-Market

0.79

0.00

+0.52%

Lucid Diagnostics Inc. Common Stock Profile

About

Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. Lucid Diagnostics Inc. is based in NEW YORK.

Info & Links

CEO

Lishan Aklog

Headquarters

360 MADISON AVENUE, 25TH FLOOR
NEW YORK, NY 10017, UNITED STATES

Auditor

CBIZ CPAs P.C.

Share holders

350

Employees

Lucid Diagnostics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

150.28M

Enterprise Value

140.37M

Enterprise Value/EBITDA(ttm)

-2.82

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

30.01

Price to Book(mrq)

14.94

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-22.79%

Operating Margin(ttm)

-915.02%

Profit Margin(ttm)

-1204.89%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-643.66%

Return on Assets(ttm)

-119.57%

Income Statement

Revenue(ttm)

5.45M

Revenue Per Share(ttm)

0.03

Gross Profit(ttm)

-1.18M

EBITDA(ttm)³

-49.81M

Net Income Available to Common(ttm)

-65.01M

Diluted EPS(ttm)

-0.47

Share Statistics

Beta (5Y Monthly)

1.10

52-Week Change

-23.25%

S&P 500 52-Week Change

18.73%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

203.07M

Dividend Yield

0.00%

Float⁴

189.22M

% Held by Insiders

6.90%

% Held by Institutions

74.01%

Balance Sheet

Total Cash(mrq)

33.40M

Total Cash Per Share(mrq)

0.16

Total Debt(mrq)

23.50M

Total Debt/Equity(mrq)

215.06%

Current Ratio(mrq)

1.33%

Quick Ratio(mrq)

1.31%

Book Value Per Share(mrq)

0.06

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.13

Free Cash Flow(ytd)

-23.63M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.